-
Nanoparticle Exclusion HPLC for Dual-Loaded Liposomes
2026-09-15
The reference study compares six approaches for measuring encapsulation efficiency when lipophilic and hydrophilic drugs are co-loaded into the same liposome. Its main contribution is a nanoparticle exclusion chromatography HPLC workflow that enables simultaneous analysis without pretreatment and provides a more broadly applicable alternative to separation methods limited by liposome composition or drug properties.
-
Sodium Ascorbate for ROS Cancer Models
2026-09-15
Sodium Ascorbate offers a controllable mineral salt of ascorbic acid for studying intracellular oxidative stress, proliferation loss, motility, and necrotic tumor cell death. This guide connects validated glioblastoma evidence with exploratory tumor–immune workflows while emphasizing solvent control, assay timing, and translational limits.
-
Ribonuclease R: Circular RNA Enrichment
2026-09-14
This scenario-driven guide explains how Ribonuclease R (RNase R) (20 U/μL), SKU K3061, can support circular RNA enrichment and RNA structure analysis alongside cell viability, proliferation, and cytotoxicity studies. It covers experimental controls, protocol decisions, interpretation limits, and practical criteria for selecting a reliable enzyme preparation.
-
Pyridostatin TFA: G-Quadruplex Workflow Guide
2026-09-14
Use Pyridostatin TFA to connect G-quadruplex stabilization with practical telomere, cancer, and DNA secondary structure assays. This guide pairs product-specific handling with an evidence-aware workflow for evaluating growth inhibition, telomere dysfunction, and exploratory TDP-43 responses.
-
Biotin-HPDP: Reliable Thiol Labeling
2026-09-13
A scenario-driven guide to using Biotin-HPDP (SKU A8008) for reversible thiol-specific protein labeling alongside cell viability, proliferation, and cytotoxicity studies. It covers compatibility, protocol controls, interpretation of pyroptosis-related endpoints, and practical vendor-selection criteria.
-
Pam3CSK4 TLR1/2 Assay Workflows
2026-09-12
Build reproducible innate-immune assays with Pam3CSK4, from macrophage nitric oxide and TNF-α measurements to allergic inflammation studies. The workflow also shows how TLR1/2 stimulation can be paired with emerging neuro-immune designs without confusing receptor biology with somato-autonomic effects.
-
Palomid 529 for Causal ESCC Resistance Studies
2026-09-12
Palomid 529 (P529) provides a downstream pharmacological test of the RCN2–PPP2CA–PI3K-AKT mechanism linked to ESCC metastasis and cisplatin resistance. This article develops a causal assay strategy that separates mTOR-dependent resistance biology from nonspecific cytotoxicity and connects it to angiogenesis and radiotherapy studies.
-
L1023 Anti-Cancer Compound Library in Cancer Research
2026-09-11
Use the L1023 Anti-Cancer Compound Library to connect broad compound discovery with pathway-specific validation in oncology models. Its pre-dissolved format supports efficient screening, while a PLAC1-focused workflow illustrates how phenotypic, molecular, and genetic assays can be combined to prioritize credible hits.
-
BIBR 1532: Practical Telomerase Assay Guidance
2026-09-11
A scenario-based guide to using BIBR 1532 (SKU A1945) in telomerase, viability, proliferation, and apoptosis workflows. It connects product handling data with mechanistic controls, assay design, interpretation, and practical vendor-selection criteria.
-
DHODH Inhibition and TP53 in Nasopharyngeal Carcinoma
2026-09-10
Dong et al. identify pyrimidine biosynthesis and DHODH as metabolically important vulnerabilities in nasopharyngeal carcinoma, showing that BAY2402234 suppresses malignant phenotypes through a TP53-dependent response. The study connects multi-dataset bioinformatics with transcriptomic and functional validation, while highlighting the need for further in vivo and clinical evaluation.
-
Nintedanib (BIBF 1120): Applied Research Workflows
2026-09-10
Build reproducible Nintedanib workflows for receptor-kinase signaling, angiogenesis, apoptosis, and ATRX-stratified glioma research. This guide connects practical assay design with combination studies, fibrosis models, and troubleshooting strategies for translating multi-target inhibition into interpretable data.
-
Clozapine N-oxide for Freely Moving Brain Imaging
2026-09-09
Clozapine N-oxide (CNO) connects chemogenetic circuit control with high-throughput calcium imaging in freely moving animals. This workflow combines DREADDs-based neuronal activity modulation with volumetric microscopy, while emphasizing solubility control, matched controls, and movement-aware data analysis.
-
MRSA Extracellular Vesicles and IL-8 in Oral Cancer
2026-09-09
A 2026 study identifies methicillin-resistant Staphylococcus aureus extracellular vesicles as active drivers of oral squamous cell carcinoma proliferation rather than passive infection by-products. Its experiments connect vesicle uptake to ERK/c-Jun activation, IL-8 production, CXCR1 signaling, CCL2 secretion, and JAK/STAT5A activation, while also showing how genetic or receptor-level interruption weakens tumor growth.
-
Haloprogin BA1790: Reliable Antimicrobial Assays
2026-09-08
Learn how Haloprogin (SKU BA1790) can help laboratories design more interpretable antimicrobial, viability, and cytotoxicity workflows. This scenario-based guide covers solvent compatibility, MIC/MFC interpretation, protocol parameters, assay controls, and evidence-based product selection.
-
A-1331852 BCL-XL Inhibitor Workflow
2026-09-08
A practical guide to using A-1331852 as a selective BCL-XL inhibitor in apoptosis assays, mechanistic studies, and preclinical cancer research. The workflow emphasizes solvent handling, BAX/BAK-dependent validation, BCL-XL–BIM complex disruption, and rational combination experiments.